CCMG
GSK icon

Clark Capital Management Group’s GSK GSK Stock Holding History

Clark Capital Management Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,779,776
Closed -$68.3M – 454
2025
Q2 		$68.3M Buy
1,779,776
+214,041
+14% +$8.18M 0.47% 59
2025
Q1 		$60.7M Buy
1,565,735
+908,284
+138% +$33.3M 0.43% 69
2024
Q4 		$22.2M Sell
657,451
-623,938
-49% -$22.5M 0.16% 143
2024
Q3 		$52.4M Sell
1,281,389
-574,738
-31% -$23.5M 0.36% 85
2024
Q2 		$71.5M Buy
1,856,127
+39,072
+2% +$1.64M 0.53% 53
2024
Q1 		$77.9M Buy
1,817,055
+60,418
+3% +$2.49M 0.58% 41
2023
Q4 		$65.1M Buy
1,756,637
+679,375
+63% +$24.4M 0.53% 45
2023
Q3 		$39.1M Buy
1,077,262
+34,915
+3% +$1.24M 0.39% 78
2023
Q2 		$37.1M Buy
1,042,347
+34,353
+3% +$1.23M 0.33% 89
2023
Q1 		$35.9M Buy
1,007,994
+30,650
+3% +$1.07M 0.4% 80
2022
Q4 		$34.3M Sell
977,344
-136,181
-12% -$4.54M 0.32% 85
2022
Q3 		$32.8M Buy
1,113,525
+285,111
+34% +$10.8M 0.43% 62
2022
Q2 		$45.1M Buy
828,414
+39,711
+5% +$2.19M 0.59% 34
2022
Q1 		$42.9M Buy
788,703
+308,431
+64% +$16.8M 0.48% 50
2021
Q4 		$26.5M Buy
+480,272
New +$25M 0.32% 129
2016
Q3 		– Sell
-47,062
Closed -$2.55M – 308
2016
Q2 		$2.55M Buy
+47,062
New +$2.48M 0.17% 145
2014
Q3 		– Sell
-4,286
Closed -$287K – 317
2014
Q2 		$287K Hold
4,286
– – 0.02% 261
2014
Q1 		$286K Hold
4,286
– – 0.02% 273
2013
Q4 		$286K Sell
4,286
-111
-3% -$7.2K 0.02% 274
2013
Q3 		$276K Buy
4,397
+99
+2% +$6.37K 0.02% 289
2013
Q2 		$268K Buy
+4,298
New +$273K 0.02% 273

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clark Capital Management Group's GSK Position: Q3 2025 in Review

Clark Capital Management Group sold out of GSK (GSK) in Q3 2025, closing a stake of 1,779,776 shares — an estimated $68.3M sold.

Clark Capital Management Group first reported a position in GSK in Q2 2013 and held it in 21 quarters. The position peaked at $77.9M in Q1 2024. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Clark Capital Management Group reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Clark Capital Management Group sold 1,779,776 GSK shares in Q3 2025, an estimated $68.3M.
  • Clark Capital Management Group first reported a position in GSK in Q2 2013 and held it in 21 quarters.
  • Clark Capital Management Group's GSK position peaked at $77.9M in Q1 2024.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Clark Capital Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.